Developer docs
API playgroundTry for free, no card

Search company profiles

Mabo Farma

Full company profile

uuid002oumf

Namestring
Mabo Farma
Legal namestring
MABO FARMA S.A.
Websiteurl
mabofarma.com
Company typeenum
Private
Founded yearint
1997
Descriptiontext

Mabo Farma (MABO FARMA S.A.) is a Spanish pharmaceutical laboratory founded in 1997 and headquartered in Madrid, operating a dual-brand portfolio in two adjacent categories. The MABOFARMA brand comprises a broad range of generic pharmaceutical medications (Especialistas en Medicamentos Genéricos) spanning 12 therapeutic areas — anti-infective, anti-inflammatory/analgesic, digestive, cardiovascular, ophthalmological, oncological, osteoarticular, respiratory, mental health, CNS, urological, and OTC — with approximately 80+ branded generic SKUs (e.g., Omeprazol Mabo, Paracetamol Mabo, Atorvastatina Mabo, Escitalopram Mabo). The MABONATUR sub-brand offers 40+ premium food supplements and therapeutic cosmetics across digestive, immune, bone and joint, cardiovascular, women's health, urinary, magnesium, and sleep/relaxation categories, with recent innovations including the 100% Organic Magnesium line (citrate, malate, glycinate) and the PROBalans OmniBoost symbiotic probiotic formula.

Manufacturing is certified to EU GMP, HACCP, and CFR21 quality standards. Since 2023, Mabo Farma has operated as part of PharmaS Group, an international pharmaceutical conglomerate with presence in 12 countries, 3 manufacturing facilities, approximately 500 employees globally, and production capacity of roughly 30 million products per year. The business model is dual-channel: generic medications are dispensed through Spanish pharmacies under National Code (CN) identification, while Mabonatur products are sold exclusively through pharmacies supplemented by direct-to-consumer e-commerce at mabonatur.com. The company supports its pharmacy channel with HCP education programs (Mabo Talks, Espacio Farma), a 60,000+ subscriber email newsletter, and active social media presence. Pricing is not publicly disclosed, and revenue figures are not available in the source material.

Short descriptiontext

Mabo Farma is a Spanish pharmaceutical laboratory (founded 1997, Madrid) that manufactures generic medications across 12 therapeutic areas and operates the MABONATUR premium food supplement and therapeutic cosmetics brand, distributed primarily through Spanish pharmacies and DTC e-commerce. Since 2023 it has been a subsidiary of PharmaS Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCoslada, Spain
HQ citystring
Coslada
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceuticals, food supplements, therapeutic cosmetics, digestive health, immune support
Industry1 code
PRIMARYHLAIABAL
Generic Hospital & Institutional Products
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Generic Pharmaceuticals
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Generic Medications (EFG)
TypeOne Time License
Description

Mabo Farma produces and sells generic pharmaceutical products (Especialistas en Medicamentos Genéricos) across multiple therapeutic areas including cardiovascular, mental health, anti-inflammatory, digestive, respiratory, and more. Products include branded generics like Omeprazol Mabo, Paracetamol Mabo, Amlodipino Mabo, etc.

mabofarma.com
2Mabonatur Food Supplements
TypeOne Time License
Description

Premium food supplements and therapeutic cosmetics sold exclusively through pharmacies and direct-to-consumer e-commerce. Product lines include probiotics, magnesium supplements, vitamins, minerals, herbal extracts, collagen products, andCBD-based products.

mabofarma.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1MABONATUR
Description

Premium food supplements and therapeutic cosmetics line designed to offer the best of nature and science for pharmaceutical recommendation.

mabofarma.com
Core offering1 text field

Mabo Farma manufactures and sells a broad portfolio of generic pharmaceutical medications (EFG) covering cardiovascular, mental health, anti-inflammatory, digestive, respiratory, and other therapeutic areas. Under its MABONATUR sub-brand, it also produces and markets premium food supplements and therapeutic cosmetics (probiotics, magnesium, vitamins, herbal extracts, collagen, CBD creams) sold exclusively through pharmacies and a direct-to-consumer e-commerce store.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 80% of population takes less magnesium than recommended (ANIBES study cited)
Product overview1 text field

Mabo Farma operates as a dual-brand pharmaceutical company with two distinct product lines: (1) MABOFARMA Generic Medications - a comprehensive portfolio of generic pharmaceutical drugs covering 12 therapeutic areas (ANTIINFECCIOSA, ANTIINFLAMATORIA ANALGÉSICA, DIGESTIVO, CARDIOVASCULAR, OFTALMOLÓGICA, ONCOLÓGICA, OSTEOARTICULAR, RESPIRATORIO, SALUD MENTAL, SNC, UROLOGÍA, and OTC) including approximately 80+ products such as cardiovascular medications (Amlodipino, Atorvastatina, Losartán), CNS medications (Alprazolam, Escitalopram, Venlafaxina), gastrointestinal medications (Esomeprazol, Lansoprazol, Omeprazol), pain/inflammation medications (Ibuprofeno, Dexketoprofeno), and many others; and (2) MABONATUR - a premium food supplement and therapeutic cosmetics sub-brand offering 40+ products across therapeutic categories including cardiovascular (MABOLIPID, MABOFERRO), bones & joints (MABOFLEX line with multiple variants, K2 & D3), digestive health (MABOBÍFIDUS probiotics, DIGESTIN ENZYMES, PROBalans® OmniBoost, GASTROMABO), immune support (MABODEFENSAS, PROBETAGLUKAN®, INMUNO C D© FORTE, ALIBRA), women's health (FEMIPAUSE, FÓLICO ACTIVO QUATREFOLIC), urinary health (MABOCYST D-mannose products), magnesium supplements (MAGNESIO CITRATO, MALATO, GLICINATO - 100% organic), sleep/relaxation (MABO SUEÑO, MABO MELATONINA KIDS, TRIPTÓFANO), and therapeutic cosmetics (MABODOL CBD cream, MABODERM line). The company emphasizes Science and Conscience ('Ciencia y Conciencia') in product development, using rigorously selected active ingredients backed by clinical studies, with EU GMP, HACCP, and CFR21 certified manufacturing. Since 2023, Mabo Farma is part of the international PharmaS Group.

Product and service1 record
1MABOFARMA Generic Medications (EFG)
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

French pharmaceutical laboratory specializing in natural and botanical food supplements sold primarily through pharmacies; directly comparable to Mabo Farma's MABONATUR line on category, formulation approach, and pharmacy-exclusive distribution.

TypeRegional player
Description

Spanish pharmaceutical company headquartered in Barcelona with a focus on dermatology and specialty products; comparable as a Spain-based pharma peer but differentiated by therapeutic focus and prescription-led rather than OTC/supplement-led model.

3Sandoz
TypeBroad incumbent
Description

Novartis' generics and biosimilars division with extensive European operations; competes with Mabo Farma across generic categories and increasingly in differentiated generics and consumer health adjacencies.

TypeDirect peer
Description

German generics brand now part of Teva, with broad European generics distribution; comparable to Mabo Farma as a multi-country generics manufacturer with strong pharmacy-channel presence across Europe.

5Cinfa
TypeDirect peer
Description

Spanish generic pharmaceutical manufacturer headquartered in Pamplona with a broad portfolio across cardiovascular, CNS, and other therapeutic areas, distributing primarily through Spanish pharmacies — directly comparable in scale, channel, and product breadth to Mabo Farma.

TypeBroad incumbent
Description

Global pharmaceutical company formed from Mylan and Pfizer's Upjohn, with a substantial generics portfolio across European markets; competes with Mabo Farma in established generic molecules while operating at significantly larger scale.

TypeDirect peer
Description

Barcelona-based Spanish generics laboratory with a comprehensive EFG portfolio and growing consumer health / biosimilars presence; comparable to Mabo Farma in generics focus, therapeutic breadth, and pharmacy distribution.

TypeDirect peer
Description

Spanish generic pharmaceutical laboratory headquartered in Tres Cantos (Madrid) producing a wide portfolio of oral solid and injectable generics distributed through pharmacies — directly comparable to Mabo Farma on geography, category, and channel.

TypeBroad incumbent
Description

German-headquartered European generics and consumer healthcare company with a strong pharmacy-channel portfolio; comparable to Mabo Farma on combining generics with branded consumer health products sold through pharmacies.

TypeBroad incumbent
Description

Global leader in generic medicines with a deep Spanish and European footprint; a broad incumbent competing against Mabo Farma across multiple generic molecules while also offering specialty and biosimilar products.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mabo Farma

Generic Pharmaceuticalsmabofarma.com

Mabo Farma is a Spanish pharmaceutical laboratory (founded 1997, Madrid) that manufactures generic medications across 12 therapeutic areas and operates the MABONATUR premium food supplement and therapeutic cosmetics brand, distributed primarily through Spanish pharmacies and DTC e-commerce. Since 2023 it has been a subsidiary of PharmaS Group.

What Mabo Farma does

Mabo Farma (MABO FARMA S.A.) is a Spanish pharmaceutical laboratory founded in 1997 and headquartered in Madrid, operating a dual-brand portfolio in two adjacent categories. The MABOFARMA brand comprises a broad range of generic pharmaceutical medications (Especialistas en Medicamentos Genéricos) spanning 12 therapeutic areas — anti-infective, anti-inflammatory/analgesic, digestive, cardiovascular, ophthalmological, oncological, osteoarticular, respiratory, mental health, CNS, urological, and OTC — with approximately 80+ branded generic SKUs (e.g., Omeprazol Mabo, Paracetamol Mabo, Atorvastatina Mabo, Escitalopram Mabo). The MABONATUR sub-brand offers 40+ premium food supplements and therapeutic cosmetics across digestive, immune, bone and joint, cardiovascular, women's health, urinary, magnesium, and sleep/relaxation categories, with recent innovations including the 100% Organic Magnesium line (citrate, malate, glycinate) and the PROBalans OmniBoost symbiotic probiotic formula.

Manufacturing is certified to EU GMP, HACCP, and CFR21 quality standards. Since 2023, Mabo Farma has operated as part of PharmaS Group, an international pharmaceutical conglomerate with presence in 12 countries, 3 manufacturing facilities, approximately 500 employees globally, and production capacity of roughly 30 million products per year. The business model is dual-channel: generic medications are dispensed through Spanish pharmacies under National Code (CN) identification, while Mabonatur products are sold exclusively through pharmacies supplemented by direct-to-consumer e-commerce at mabonatur.com. The company supports its pharmacy channel with HCP education programs (Mabo Talks, Espacio Farma), a 60,000+ subscriber email newsletter, and active social media presence. Pricing is not publicly disclosed, and revenue figures are not available in the source material.

Mabo Farma firmographics

Firmographics
Name
Mabo Farma
Legal name
MABO FARMA S.A.
Website
https://mabofarma.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
51–100 employees
Short description
Mabo Farma is a Spanish pharmaceutical laboratory (founded 1997, Madrid) that manufactures generic medications across 12 therapeutic areas and operates the MABONATUR premium food supplement and therapeutic cosmetics brand, distributed primarily through Spanish pharmacies and DTC e-commerce. Since 2023 it has been a subsidiary of PharmaS Group.
Ownership category
akta.pro rank

Mabo Farma industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIABAL
Generic Hospital & Institutional Products

Keywords

  • Generic pharmaceuticals
  • Food supplements
  • Therapeutic cosmetics
  • Digestive health
  • Immune support

Where Mabo Farma is headquartered

Location

Headquarters

HQ city
Coslada
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Mabo Farma business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Generic Medications (EFG): Mabo Farma produces and sells generic pharmaceutical products (Especialistas en Medicamentos Genéricos) across multiple therapeutic areas including cardiovascular, mental health, anti-inflammatory, digestive, respiratory, and more. Products include branded generics like Omeprazol Mabo, Paracetamol Mabo, Amlodipino Mabo, etc.
  2. Mabonatur Food Supplements: Premium food supplements and therapeutic cosmetics sold exclusively through pharmacies and direct-to-consumer e-commerce. Product lines include probiotics, magnesium supplements, vitamins, minerals, herbal extracts, collagen products, andCBD-based products.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Mabo Farma product offering

Product offering

Core offering

Mabo Farma manufactures and sells a broad portfolio of generic pharmaceutical medications (EFG) covering cardiovascular, mental health, anti-inflammatory, digestive, respiratory, and other therapeutic areas. Under its MABONATUR sub-brand, it also produces and markets premium food supplements and therapeutic cosmetics (probiotics, magnesium, vitamins, herbal extracts, collagen, CBD creams) sold exclusively through pharmacies and a direct-to-consumer e-commerce store.

Product overview

Mabo Farma operates as a dual-brand pharmaceutical company with two distinct product lines: (1) MABOFARMA Generic Medications - a comprehensive portfolio of generic pharmaceutical drugs covering 12 therapeutic areas (ANTIINFECCIOSA, ANTIINFLAMATORIA ANALGÉSICA, DIGESTIVO, CARDIOVASCULAR, OFTALMOLÓGICA, ONCOLÓGICA, OSTEOARTICULAR, RESPIRATORIO, SALUD MENTAL, SNC, UROLOGÍA, and OTC) including approximately 80+ products such as cardiovascular medications (Amlodipino, Atorvastatina, Losartán), CNS medications (Alprazolam, Escitalopram, Venlafaxina), gastrointestinal medications (Esomeprazol, Lansoprazol, Omeprazol), pain/inflammation medications (Ibuprofeno, Dexketoprofeno), and many others; and (2) MABONATUR - a premium food supplement and therapeutic cosmetics sub-brand offering 40+ products across therapeutic categories including cardiovascular (MABOLIPID, MABOFERRO), bones & joints (MABOFLEX line with multiple variants, K2 & D3), digestive health (MABOBÍFIDUS probiotics, DIGESTIN ENZYMES, PROBalans® OmniBoost, GASTROMABO), immune support (MABODEFENSAS, PROBETAGLUKAN®, INMUNO C D© FORTE, ALIBRA), women's health (FEMIPAUSE, FÓLICO ACTIVO QUATREFOLIC), urinary health (MABOCYST D-mannose products), magnesium supplements (MAGNESIO CITRATO, MALATO, GLICINATO - 100% organic), sleep/relaxation (MABO SUEÑO, MABO MELATONINA KIDS, TRIPTÓFANO), and therapeutic cosmetics (MABODOL CBD cream, MABODERM line). The company emphasizes Science and Conscience ('Ciencia y Conciencia') in product development, using rigorously selected active ingredients backed by clinical studies, with EU GMP, HACCP, and CFR21 certified manufacturing. Since 2023, Mabo Farma is part of the international PharmaS Group.

Differentiator

Problem solved

Functional benefit

Brands

  • MABONATUR: Premium food supplements and therapeutic cosmetics line designed to offer the best of nature and science for pharmaceutical recommendation.

Products and services

  • MABOFARMA Generic Medications (EFG)

Quantifiable outcome

  • 80% of population takes less magnesium than recommended (ANIBES study cited)

Companies that use Mabo Farma

Customer profile

Segments2 records

Ideal customer profiles2 records

Mabo Farma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Mabo Farma partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Mabo Farma competitors and assessment

Company assessment

Direct peers

  • Arkopharma: French pharmaceutical laboratory specializing in natural and botanical food supplements sold primarily through pharmacies; directly comparable to Mabo Farma's MABONATUR line on category, formulation approach, and pharmacy-exclusive distribution.
  • Ratiopharm: German generics brand now part of Teva, with broad European generics distribution; comparable to Mabo Farma as a multi-country generics manufacturer with strong pharmacy-channel presence across Europe.
  • Cinfa: Spanish generic pharmaceutical manufacturer headquartered in Pamplona with a broad portfolio across cardiovascular, CNS, and other therapeutic areas, distributing primarily through Spanish pharmacies — directly comparable in scale, channel, and product breadth to Mabo Farma.
  • Kern Pharma: Barcelona-based Spanish generics laboratory with a comprehensive EFG portfolio and growing consumer health / biosimilars presence; comparable to Mabo Farma in generics focus, therapeutic breadth, and pharmacy distribution.
  • Normon: Spanish generic pharmaceutical laboratory headquartered in Tres Cantos (Madrid) producing a wide portfolio of oral solid and injectable generics distributed through pharmacies — directly comparable to Mabo Farma on geography, category, and channel.

Regional players

  • Almirall: Spanish pharmaceutical company headquartered in Barcelona with a focus on dermatology and specialty products; comparable as a Spain-based pharma peer but differentiated by therapeutic focus and prescription-led rather than OTC/supplement-led model.

Broad incumbents

  • Sandoz: Novartis' generics and biosimilars division with extensive European operations; competes with Mabo Farma across generic categories and increasingly in differentiated generics and consumer health adjacencies.
  • Viatris: Global pharmaceutical company formed from Mylan and Pfizer's Upjohn, with a substantial generics portfolio across European markets; competes with Mabo Farma in established generic molecules while operating at significantly larger scale.
  • Stada Arzneimittel: German-headquartered European generics and consumer healthcare company with a strong pharmacy-channel portfolio; comparable to Mabo Farma on combining generics with branded consumer health products sold through pharmacies.
  • Teva Pharmaceutical Industries: Global leader in generic medicines with a deep Spanish and European footprint; a broad incumbent competing against Mabo Farma across multiple generic molecules while also offering specialty and biosimilar products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Mabo Farma social profiles

Digital presence

Mabo Farma compliance and trust

Trust signal

Compliance3 records

Mabo Farma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mabo Farma leadership team

Management profile

Number of profiles

Profiles5 records

Mabo Farma subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Mabo Farma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mabo Farma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mabo Farma

What does Mabo Farma do?

Mabo Farma manufactures and sells a broad portfolio of generic pharmaceutical medications (EFG) covering cardiovascular, mental health, anti-inflammatory, digestive, respiratory, and other therapeutic areas. Under its MABONATUR sub-brand, it also produces and markets premium food supplements and therapeutic cosmetics (probiotics, magnesium, vitamins, herbal extracts, collagen, CBD creams) sold exclusively through pharmacies and a direct-to-consumer e-commerce store.

Is Mabo Farma a public or private company?

Mabo Farma is a private company. It is classified as corporate owned and is currently operating.

When was Mabo Farma founded?

Mabo Farma was founded in 1997. It employs 51 to 100 people.

Where is Mabo Farma based?

Mabo Farma is headquartered in Coslada, Spain, in the Europe region.

How does Mabo Farma make money?

Two revenue lines are on record. Generic Medications (EFG) is the primary driver. The others are mabonatur Food Supplements.

Who are Mabo Farma's main competitors?

Direct peers on record are Arkopharma, Ratiopharm, Cinfa, Kern Pharma and Normon. Almirall is listed as a regional player. Broad incumbents are Sandoz, Viatris, Stada Arzneimittel and Teva Pharmaceutical Industries.

Does Mabo Farma have an API?

No public API is recorded for Mabo Farma.

What industry is Mabo Farma in?

Mabo Farma's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals